Hide metadata

dc.date.accessioned2020-05-18T18:02:44Z
dc.date.available2020-05-18T18:02:44Z
dc.date.created2020-01-09T14:21:19Z
dc.date.issued2019
dc.identifier.citationSkånland, Sigrid Strand Cieslar-Pobuda, Artur . Off-label uses of drugs for depression. European Journal of Pharmacology. 2019, 865
dc.identifier.urihttp://hdl.handle.net/10852/75869
dc.description.abstractThe prescription of drugs for depression is rising rapidly. One of the reasons for this trend is their many off-label uses. Up to one third of all prescriptions are for non-indicated use, which in addition to drug repurposing includes different dosing or duration than those recommended. In this review, we elaborate on what antidepressants can treat besides depression. The five classes of drugs for depression are introduced, and their mechanisms of action and serious side effects are described. The most common off-label uses of antidepressants are discussed, with a special focus on treating eating disorders, sleep problems, smoking cessation and managing chronic pain. Depression is often a comorbidity when antidepressants are chosen as therapy, but good therapeutic effects have been observed for other conditions also when depression is not involved. Finally, a new type of antidepressant developed from the hallucinogenic “party drug” ketamine is briefly introduced. This recent development suggests that antidepressants will keep playing a central role in medicine for years to come.en_US
dc.languageEN
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleOff-label uses of drugs for depressionen_US
dc.typeJournal articleen_US
dc.creator.authorSkånland, Sigrid Strand
dc.creator.authorCieslar-Pobuda, Artur
cristin.unitcode185,53,49,12
cristin.unitnameInstitutt for kreftforskning
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin1769539
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=European Journal of Pharmacology&rft.volume=865&rft.spage=&rft.date=2019
dc.identifier.jtitleEuropean Journal of Pharmacology
dc.identifier.volume865
dc.identifier.doihttps://doi.org/10.1016/j.ejphar.2019.172732
dc.identifier.urnURN:NBN:no-79009
dc.type.documentTidsskriftartikkelen_US
dc.type.peerreviewedPeer reviewed
dc.source.issn0014-2999
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/75869/2/Off-label%2Buses%2Bof%2Bdrugs%2Bfor%2Bdepression.pdf
dc.type.versionPublishedVersion
cristin.articleid172732
dc.relation.projectKF/145311
dc.relation.projectNFR/187615


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial-NoDerivatives 4.0 International
This item's license is: Attribution-NonCommercial-NoDerivatives 4.0 International